SCHEMBL28055976

SCHEMBL28055976

Clc1ccc(C/N=N/Cc2ccc(Cl)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.50
TAAR1 Q96RJ0 4/20 0.48
LMNA P02545 1/20 0.47
CYP2A6 P11509 1/20 0.47
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR3A P46098 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
MIF P14174 1/20 0.46
AGXT P21549 2/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A2 P23975 2/20 0.41
SLC6A3 Q01959 2/20 0.41
HTR2A P28223 1/20 0.41
HRH1 P35367 1/20 0.41
HTR2B P41595 1/20 0.41
CHRNA4 P43681 1/20 0.41
GRIN2B Q13224 1/20 0.41
C3AR1 Q16581 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564229 0.85 TAAR1 (0.47) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL943888 0.82 IDO1 (0.50) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL2090624 0.80 IDO1 (0.48) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL12121938 0.78 IDO1 (0.46) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL11478072 0.78 IDO1 (0.46) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL16775681 0.78 IDO1 (0.46) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL13435556 0.78 TAAR1 (0.41) IDO1TAAR1LMNACYP2A6HTR3E
SCHEMBL18835003 0.77 AOC3 (0.41) IDO1TAAR1HTR3EHTR3BHTR3A
SCHEMBL9232607 0.76 TAAR1 (0.40) IDO1TAAR1HTR3EHTR3BHTR3A
SCHEMBL2091029 0.74 MAOB (0.48) IDO1TAAR1LMNACYP2A6AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105530932-B Primary formamide as BTK inhibitor 艾伯维公司 2019-09-27 CN disclosed
CN-105530932-A Primary carboxamides as BIK inhibitors ABBVIE INC 2016-04-27 CN disclosed